Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Drug Makers Preparing To Make Japanese Utilization Goal A Reality

This article was originally published in PharmAsia News

Executive Summary

TOKYO - The Japan Generic Medicines Association released survey results July 9 saying its 40 member companies are gearing up to manufacture considerably more generics in the next few years. Generic drug makers say they are meeting expectations set by the Ministry of Health, Labour and Welfare to raise Japan's generic drug use share for prescriptions from the current 17 percent to the government goal of 30 percent by fiscal year 2012

You may also be interested in...



Japan Vows Anew To Overcome Reluctance To Boost Generics Use

Despite slow adoption, the potential for massive shift in Japan’s branded-generics market is a draw for foreign firms as policymakers see increased usage as key to containing health costs.

Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi In Hot Pursuit Of Sources Of Innovation in Asia: An Interview with PharmAsia News

During the last few weeks Roche has been in hot pursuit of sources of innovation, including the proposed acquisition of partner Genentech. In the same week it acquired antibody screening company Arius, RNAi company Mirus and made three more deals that the company will not announce. Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi sat down with the PharmAsia News Australia bureau to discuss what Roche is looking for in its partners and its current partnership with Roche's Japan partner Chugai.

Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi In Hot Pursuit Of Sources Of Innovation in Asia: An Interview with PharmAsia News

During the last few weeks Roche has been in hot pursuit of sources of innovation, including the proposed acquisition of partner Genentech. In the same week it acquired antibody screening company Arius, RNAi company Mirus and made three more deals that the company will not announce. Roche Pharma Japan General Manager and Asia Regional Head-Pharma Partnering Mark Noguchi sat down with the PharmAsia News Australia bureau to discuss what Roche is looking for in its partners and its current partnership with Roche's Japan partner Chugai.

Related Content

UsernamePublicRestriction

Register

RS150180

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel